• Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Germany The Netherlands Spain
  • Study on the Effects of Vidofludimus Calcium in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Estonia Germany Poland Romania
  • Study on the Effects of Follitropin Beta and Corifollitropin Alfa for Patients with Subfertility Undergoing ICSI Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Denmark Finland France +6
  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Romania
  • Study of Rivaroxaban versus standard care in patients with excessive atrial ectopy or short atrial runs who have high risk of blood clots

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on the Effectiveness and Safety of STN1010904 Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effect of Cemiplimab in Patients with Oligometastatic Non-Small Cell Lung Cancer After Radical Treatment

    Not recruiting

    4 1 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain
  • Study of Monalizumab for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Haploidentical Transplantation

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy
  • Study on the Effects of Dexmedetomidine on Neuroinflammation in COVID-19 ARDS Survivors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France

powered by